Recent economic evaluations have been undertaken with a specific focus on pharmaceutical intervention related to treatment of BPH. Specifically for the DUT + TAM FDC vs. tamsulosin monotherapy ...
Tamsulosin is an alpha-blocker medication designed to alleviate the symptoms caused by an enlarged prostate. Relaxing the muscles in both the prostate and bladder facilitates smoother urine flow ...
Data suggest that medical therapy, particularly with subtype-selective a 1-AR antagonists (eg, tamsulosin), can effectively alleviate BPH symptoms and improve QOL measures, without causing adverse ...
New data have prompted calls for the safety information provided with tamsulosin tablets to be reassessed. Blockade of α 1a-adrenergic receptors in the smooth muscle of the prostate and bladder ...
in men with overactive bladder and benign prostatic hyperplasia. With regard to efficacy, 80% of patients receiving tolterodine ER plus tamsulosin had perceived a benefit from their treatment ...
versus tamsulosin monotherapy, in the treatment of patients with benign prostatic hyperplasia (BPH) from the perspective of the Greek healthcare insurance system. Methods A Microsoft Excel-based ...